Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation (Q33247384)

24 July 2017

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation (English)

1 reference

24 July 2017

1 reference

1 reference

Maen Abdelrahim

1

1 reference

24 July 2017

Cheryl H Baker

series ordinal

2

1 reference

24 July 2017

James L Abbruzzese

series ordinal

3

1 reference

24 July 2017

Stephen Safe

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

Journal of the National Cancer Institute

24 July 2017

1 reference

24 July 2017

98

1 reference

24 July 2017

12

1 reference

24 July 2017

855-868

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

24 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

A prospective study of aspirin use and the risk of pancreatic cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Aspirin use and pancreatic cancer mortality in a large United States cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Regular use of aspirin and pancreatic cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Regulation of the activity of Sp1-related transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Nuclear receptor-mediated transactivation through interaction with Sp proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

Aspirin and the Risk of Colorectal Cancer in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ232

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ232

1 reference

24 July 2017

1 reference